Efficacy of Generic Imatinib After Switching from Original in Treatment of Patients with Chronic Myeloid Leukemia in the Republic of North Macedonia - A Single-Center Experience

被引：0
|
作者：
Dukovski, Dushko [1 ]
Trajkova, Sanja [1 ]
Stojanovska, Simona [1 ]
Ridova, Nevenka [1 ]
Panovska-Stavridis, Irina [1 ]
机构：
[1] Clin Hematol, Skopje, North Macedonia
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷
关键词：
CML; imatinib; selective tyrosine kinase inhibitor (TKI); chronic myeloid leukemia;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CML-104
引用
收藏
页码：S232 / S232
页数：1
相关论文
共 50 条
  • [31] The impact of early molecular response in children and adolescents with chronic myeloid leukemia treated with imatinib: a single-center study from China
    Shao, Haigang
    Zeng, Zhao
    Cen, Jiannong
    Zhang, Jun
    Bai, Shuxiao
    Wu, Chunxiao
    Gong, Yanlei
    Wang, Yong
    Qiu, Huiying
    Chen, Suning
    Pan, Jinlan
    LEUKEMIA & LYMPHOMA, 2018, 59 (09) : 2152 - 2158
  • [32] Outcomes of allogenic hematopoietic cell transplantation for childhood chronic myeloid leukemia: Single-center experience
    Hafez, Hanafy A.
    Abdallah, Amr
    Hammad, Mahmoud
    Hamdy, Nayera
    Yassin, Dina
    Salem, Sherine
    Hassanain, Omayma
    Elhalaby, Lama
    Elhaddad, Alaa
    PEDIATRIC TRANSPLANTATION, 2020, 24 (04)
  • [33] Therapeutic drug monitoring of imatinib in chronic myeloid leukemia: experience from 1216 patients at a centralized laboratory
    Bouchet, Stephane
    Titier, Karine
    Moore, Nicholas
    Lassalle, Regis
    Ambrosino, Basmah
    Poulette, Sylvie
    Schuld, Peter
    Belanger, Coralie
    Mahon, Francois-Xavier
    Molimard, Mathieu
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 (06) : 690 - 697
  • [34] Ex vivo platelet morphology assessment of chronic myeloid leukemia patients before and after Imatinib treatment
    Repsold, Lisa
    Pool, Roger
    Karodia, Mohammed
    Tintinger, Gregory
    Joubert, Anna Margaretha
    MICROSCOPY RESEARCH AND TECHNIQUE, 2022, 85 (06) : 2222 - 2233
  • [35] Treatment-free remission after discontinuation of imatinib, dasatinib, and nilotinib in patients with chronic myeloid leukemia
    Han, Jae Joon
    BLOOD RESEARCH, 2023, 58 : 58 - 65
  • [36] Long-term follow-up of late chronic phase chronic myeloid leukemia patients treated with imatinib after interferon failure: a single center experience
    Pepe, Sara
    Scalzulli, Emilia
    Colafigli, Gioia
    Di Prima, Alessio
    Mancini, Marco
    Diverio, Daniela
    Latagliata, Roberto
    Martelli, Maurizio
    Foa, Robin
    Breccia, Massimo
    LEUKEMIA & LYMPHOMA, 2021, 62 (09) : 2261 - 2266
  • [37] The Impact of Cytogenetic Aberrations in the Clonal Evolution of Chronic Myeloid Leukemia: A Single-Center Experience Among 450 Turkish Patients (Cohort Study)
    Isik, Sevgi
    Gunden, Gulcin
    Teke, Hava Uskudar
    Akay, Olga Meltem
    Davutoglu, Nur Oguz
    Aslan, Vahap
    Karagulle, Mustafa
    Ozen, Hulya
    Cilingir, Oguz
    Artan, Sevilhan
    Aras, Beyhan Durak
    TURKISH JOURNAL OF HEMATOLOGY, 2022, 39 (04) : 237 - 244
  • [38] Management of chronic myeloid leukemia during pregnancy among patients treated with a tyrosine kinase inhibitor: a single-Center experience
    Assi, Rita
    Kantarjian, Hagop
    Keating, Michael
    Pemmaraju, Naveen
    Verstovsek, Srdan
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Borthakur, Gautam
    Dahl, Jenny
    Jabbour, Elias
    Cortes, Jorge E.
    LEUKEMIA & LYMPHOMA, 2021, 62 (04) : 909 - 917
  • [39] COVID-19 in Chronic-Phase Chronic Myeloid Leukemia Patients: A Single-Center Survey from Turkey
    Yilmaz, Umut
    Pekmezci, Aslihan
    Gul, Yalcin
    Eskazan, Ahmet Emre
    TURKISH JOURNAL OF HEMATOLOGY, 2021, 38 (01) : 79 - 81
  • [40] Dasatinib: From Treatment of Imatinib-Resistant or -Intolerant Patients With Chronic Myeloid Leukemia to Treatment of Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
    Abbott, Brian L.
    CLINICAL THERAPEUTICS, 2012, 34 (02) : 272 - 281
12345